248 related articles for article (PubMed ID: 29866721)
1. Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.
You Y; Wu YH; Zhang Y; Zhang L; Song Y; Bai W; Li Y; Yu Y; Kou C
BMJ Open; 2018 Jun; 8(6):e020016. PubMed ID: 29866721
[TBL] [Abstract][Full Text] [Related]
2. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents.
Zhu WF; Wang CL; Liang L; Shen Z; Fu JF; Liu PN; Lv LQ; Zhu YM
Lipids Health Dis; 2014 Jun; 13():93. PubMed ID: 24903888
[TBL] [Abstract][Full Text] [Related]
4. A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug.
Bogari NM; Aljohani A; Amin AA; Al-Allaf FA; Dannoun A; Taher MM; Elsayed A; Rednah DI; Elkhatee O; Porqueddu M; Alamanni F; Khogeer SAA; Fawzy A
BMC Cardiovasc Disord; 2019 Jan; 19(1):2. PubMed ID: 30606120
[TBL] [Abstract][Full Text] [Related]
5. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population.
Tang Y; Sun P; Guo D; Ferro A; Ji Y; Chen Q; Fan L
Atherosclerosis; 2006 Apr; 185(2):433-7. PubMed ID: 16046221
[TBL] [Abstract][Full Text] [Related]
6. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
[TBL] [Abstract][Full Text] [Related]
7. Influences of APOA5 variants on plasma triglyceride levels in Uyghur population.
Li S; Hu B; Wang Y; Wu D; Jin L; Wang X
PLoS One; 2014; 9(10):e110258. PubMed ID: 25313938
[TBL] [Abstract][Full Text] [Related]
8. Common variants in the genes of triglyceride and HDL-C metabolism lack association with coronary artery disease in the Pakistani subjects.
Shahid SU; Shabana NA; Cooper JA; Rehman A; Humphries SE
Lipids Health Dis; 2017 Jan; 16(1):24. PubMed ID: 28143480
[TBL] [Abstract][Full Text] [Related]
9. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
10. Effects of Polymorphisms in APOA4-APOA5-ZNF259-BUD13 Gene Cluster on Plasma Levels of Triglycerides and Risk of Coronary Heart Disease in a Chinese Han Population.
Fu Q; Tang X; Chen J; Su L; Zhang M; Wang L; Jing J; Zhou L
PLoS One; 2015; 10(9):e0138652. PubMed ID: 26397108
[TBL] [Abstract][Full Text] [Related]
11. Association of apolipoprotein A5 gene variants with metabolic syndrome in Tunisian population.
Kefi R; Hechmi M; Dallali H; Elouej S; Jmel H; Halima YB; Nagara M; Chargui M; Fadhel SB; Romdhane S; Kamoun I; Turki Z; Abid A; Bahri S; Bahlous A; Gomis R; Baraket A; Grigorescu F; Normand C; Jamoussi H; Abdelhak S
Ann Endocrinol (Paris); 2017 Jul; 78(3):146-155. PubMed ID: 28624160
[TBL] [Abstract][Full Text] [Related]
12. A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients.
Kim M; Kim M; Yoo HJ; Lee E; Chae JS; Lee SH; Lee JH
PLoS One; 2017; 12(12):e0186693. PubMed ID: 29211729
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A5 gene polymorphisms are associated with non-alcoholic fatty liver disease.
Xu Y; Lu LL; Liu SS; Du SX; Zhu HL; Dong QJ; Xin YN
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):214-219. PubMed ID: 29735301
[TBL] [Abstract][Full Text] [Related]
14. Association of rs662799 in APOA5 with CAD in Chinese Han population.
Chen H; Ding S; Zhou M; Wu X; Liu X; Wu Y; Liu D
BMC Cardiovasc Disord; 2018 Jan; 18(1):2. PubMed ID: 29310573
[TBL] [Abstract][Full Text] [Related]
15. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.
Liu ZK; Hu M; Baum L; Thomas GN; Tomlinson B
Atherosclerosis; 2010 Feb; 208(2):427-32. PubMed ID: 19732897
[TBL] [Abstract][Full Text] [Related]
16. APOA5 rs651821 confers increased risk for hypertension in Tongdao Dong population.
Wang H; Zhou T; He H; Peng R; Wang S; Jiang X
Clin Exp Hypertens; 2020; 42(1):81-85. PubMed ID: 30929539
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A5 gene variants are associated with decreased adiponectin levels and increased arterial stiffness in subjects with low high-density lipoprotein-cholesterol levels.
Kim M; Kim M; Yoo HJ; Bang YJ; Lee SH; Lee JH
Clin Genet; 2018 Nov; 94(5):438-444. PubMed ID: 30132804
[TBL] [Abstract][Full Text] [Related]
19. Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
Hong CJ; Chen TT; Bai YM; Liou YJ; Tsai SJ
World J Biol Psychiatry; 2012 Jan; 13(1):22-9. PubMed ID: 21375366
[TBL] [Abstract][Full Text] [Related]
20. The Association Between APOA5 Gene Polymorphisms and Plasma Lipids in the Turkish Cypriot Population: A Possible Biomarker for Preventing Cardiovascular Diseases.
Fahrioğlu U; Ergören MÇ
Biochem Genet; 2018 Jun; 56(3):176-187. PubMed ID: 29264753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
